neo1:ATPase that leads to neomycin-resistant protein when overexpressed
aacC: aminoglycoside N3\'-acetyltransferase, The enzyme can use a range of antibiotics with 2-deoxystreptamine rings as acceptor for its acetyltransferase activity, this inactivates and confers resistance to gentamicin, kanamycin, tobramycin, neomycin and apramycin amongst others.
aac3iii: Aminoglycoside N-acetyltransferase, which modifies aminoglycosides by acetylation.
aac3ix: Aminoglycoside N-acetyltransferase, which modifies aminoglycosides by acetylation.
aac3viii: Aminoglycoside N-acetyltransferase, which modifies aminoglycosides by acetylation.
aph3ia: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3ib: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3ic: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3iia: butirosin gentamincin_b kanamycin neomycin paromomycin ribostamycin
aph3iiia: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3iva: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3va: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3vb: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3via: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation.
aph3viia: Aminoglycoside O-phosphotransferase, which modifies aminoglycosides by phosphorylation. |